1. Deaton, Aimee M, Dubey, Aditi, Ward, Lucas D, Vaishnaw, Akshay K, Nioi, Paul. 2022. Rare loss of function variants in the hepatokine gene INHBE protect from abdominal obesity. In Nature communications, 13, 4319. doi:10.1038/s41467-022-31757-8. https://pubmed.ncbi.nlm.nih.gov/35896531/
2. Cao, Jiali, Zhong, Qiangqiang, Huang, Yumei, Wang, Ziwen, Xiong, Zhifan. 2023. Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease. In Biochemical and biophysical research communications, 686, 149180. doi:10.1016/j.bbrc.2023.149180. https://pubmed.ncbi.nlm.nih.gov/37922570/
3. Akbari, Parsa, Sosina, Olukayode A, Bovijn, Jonas, Verweij, Niek, Lotta, Luca A. 2022. Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes. In Nature communications, 13, 4844. doi:10.1038/s41467-022-32398-7. https://pubmed.ncbi.nlm.nih.gov/35999217/
4. Nault, Jean-Charles, Couchy, Gabrielle, Balabaud, Charles, Letouzé, Eric, Zucman-Rossi, Jessica. 2016. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation. In Gastroenterology, 152, 880-894.e6. doi:10.1053/j.gastro.2016.11.042. https://pubmed.ncbi.nlm.nih.gov/27939373/
5. Adam, Rene C, Pryce, Dwaine S, Lee, Joseph S, Sleeman, Mark W, Gusarova, Viktoria. 2023. Activin E-ACVR1C cross talk controls energy storage via suppression of adipose lipolysis in mice. In Proceedings of the National Academy of Sciences of the United States of America, 120, e2309967120. doi:10.1073/pnas.2309967120. https://pubmed.ncbi.nlm.nih.gov/37523551/
6. Sugiyama, Masakazu, Kikuchi, Akihiro, Misu, Hirofumi, Kaneko, Shuichi, Takamura, Toshinari. 2018. Inhibin βE (INHBE) is a possible insulin resistance-associated hepatokine identified by comprehensive gene expression analysis in human liver biopsy samples. In PloS one, 13, e0194798. doi:10.1371/journal.pone.0194798. https://pubmed.ncbi.nlm.nih.gov/29596463/
智鼠故事 
